title: Nanopreparations to overcome multidrug resistance in cancer.
abstract: Multidrug resistance is the most widely exploited phenomenon by which cancer eludes chemotherapy. Broad variety of factors, ranging from the cellular ones, such as over-expression of efflux transporters, defective apoptotic machineries, and altered molecular targets, to the physiological factors such as higher interstitial fluid pressure, low extracellular pH, and formation of irregular tumor vasculature are responsible for multidrug resistance. A combination of various undesirable factors associated with biological surroundings together with poor solubility and instability of many potential therapeutic small & large molecules within the biological systems and systemic toxicity of chemotherapeutic agents has necessitated the need for nano-preparations to optimize drug delivery. The physiology of solid tumors presents numerous challenges for successful therapy. However, it also offers unique opportunities for the use of nanotechnology. Nanoparticles, up to 400 nm in size, have shown great promise for carrying, protecting and delivering potential therapeutic molecules with diverse physiological properties. In this review, various factors responsible for the MDR and the use of nanotechnology to overcome the MDR, the use of spheroid culture as well as the current technique of producing microtumor tissues in vitro are discussed in detail.
authors: Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.
authors: Niravkumar R
authors: NR
authors: Patel
authors: Bhushan S
authors: BS
authors: Pattni
authors: Abraham H
authors: AH
authors: Abouzeid
authors: Vladimir P
authors: VP
authors: Torchilin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001692:Biological Transport; D004337:Drug Carriers / Q000737:chemistry*; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D006801:Humans; D058990:Molecular Targeted Therapy / Q000639:trends; D049329:Nanostructures / Q000737:chemistry*; D036103:Nanotechnology / Q000639:trends; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers
keywords: Combination therapy; Multidrug resistance; Nanopreparations; Spheroid culture
references: J Control Release. 2006 Nov 28;116(2):139-49
references: 16926059
references: Nat Rev Cancer. 2003 Oct;3(10):721-32
references: 13130303
references: Cancer Metastasis Rev. 2007 Jun;26(2):225-39
references: 17440684
references: J Control Release. 2006 Dec 1;116(3):275-84
references: 17097178
references: Mol Pharmacol. 2008 Oct;74(4):1132-40
references: 18635669
references: Clin Cancer Res. 1999 Nov;5(11):3352-6
references: 10589744
references: Oncogene. 1998 Dec 24;17(25):3225-36
references: 9916985
references: Biomaterials. 2012 Feb;33(5):1536-46
references: 22118776
references: Mol Pharm. 2011 Feb 7;8(1):185-203
references: 20942457
references: J Natl Cancer Inst Monogr. 1993;(15):55-61
references: 7912530
references: J Clin Oncol. 1998 Sep;16(9):2964-76
references: 9738565
references: Cancer Res. 1999 Dec 15;59(24):6097-102
references: 10626797
references: Nat Rev Cancer. 2006 Aug;6(8):583-92
references: 16862189
references: Mol Pharm. 2012 Oct 1;9(10):2863-74
references: 22924580
references: Nat Rev Cancer. 2002 Jun;2(6):420-30
references: 12189384
references: J Natl Cancer Inst. 1990 Mar 7;82(5):338-9
references: 2406450
references: Biomaterials. 2013 Feb;34(5):1581-90
references: 23146437
references: Clin Cancer Res. 2008 Sep 15;14(18):5810-8
references: 18794091
references: Mol Cancer Ther. 2001 Nov;1(1):69-78
references: 12467240
references: Cancer Res. 1990 Mar 15;50(6):1748-56
references: 1968358
references: Int J Pharm. 2007 Jun 7;337(1-2):329-35
references: 17275230
references: J Control Release. 2012 Nov 28;164(1):95-102
references: 22974689
references: J Invest Dermatol. 2003 Mar;120(3):476-82
references: 12603862
references: Annu Rev Pathol. 2006;1:119-50
references: 18039110
references: Br J Cancer. 2001 Nov 2;85(9):1359-67
references: 11720475
references: Biomaterials. 2012 May;33(15):3942-51
references: 22365809
references: Biomaterials. 2012 Nov;33(33):8613-24
references: 22910221
references: Mol Pharm. 2009 May-Jun;6(3):738-46
references: 19296675
references: J Control Release. 2009 Jul 1;137(1):8-14
references: 19285528
references: Biomacromolecules. 2009 Jan 12;10(1):41-8
references: 19072631
references: Curr Biol. 1999 May 20;9(10):R381-4
references: 10339421
references: Biochem Pharmacol. 1992 Aug 4;44(3):509-17
references: 1354963
references: Br J Cancer. 1997;75(8):1167-72
references: 9099966
references: Oncogene. 1999 May 27;18(21):3199-204
references: 10359525
references: J Control Release. 2008 Dec 18;132(3):164-70
references: 18571265
references: Oncogene. 2005 Mar 17;24(12):1994-2007
references: 15688031
references: J Control Release. 2009 May 21;136(1):21-9
references: 19331851
references: Cancer Res. 2000 Oct 15;60(20):5761-6
references: 11059771
references: Mol Pharm. 2011 Dec 5;8(6):2032-8
references: 21981633
references: Biomacromolecules. 2006 Mar;7(3):829-35
references: 16529420
references: Methods Enzymol. 2002;352:3-31
references: 12125356
references: Biol Pharm Bull. 2012;35(6):975-9
references: 22687542
references: Anticancer Res. 2007 Jan-Feb;27(1A):45-53
references: 17352215
references: Drug Resist Updat. 2000 Feb;3(1):39-47
references: 11498364
references: FEMS Microbiol Rev. 1998 Apr;22(1):1-20
references: 9640644
references: Curr Cancer Drug Targets. 2008 Feb;8(1):37-46
references: 18288942
references: Haematologica. 2007 Aug;92(8):1043-50
references: 17640858
references: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70
references: 9861027
references: Oncogene. 2001 Jun 21;20(28):3751-6
references: 11439338
references: ACS Nano. 2011 Feb 22;5(2):1483-94
references: 21204585
references: Breast Cancer Res Treat. 2010 Jan;119(2):255-69
references: 19221875
references: Int J Cancer. 2004 May 20;110(1):117-24
references: 15054876
references: Cancer Res. 2003 Jul 15;63(14):3919-22
references: 12873985
references: Cancer Res. 1988 May 15;48(10):2641-58
references: 3282647
references: Ann N Y Acad Sci. 2006 Oct;1082:1-8
references: 17145918
references: Bioorg Med Chem. 2006 Mar 1;14(5):1588-98
references: 16307883
references: Nature. 1998 Dec 17;396(6712):703-7
references: 9872322
references: Cell Tissue Kinet. 1979 Jan;12(1):31-42
references: 421240
references: Cancer Metastasis Rev. 2007 Mar;26(1):39-57
references: 17323127
references: Pharmacol Res. 2000 Nov;42(5):459-64
references: 11023708
references: Cancer Res. 2002 Aug 1;62(15):4282-8
references: 12154030
references: J Clin Oncol. 2005 May 20;23(15):3502-8
references: 15908660
references: Cancer Biol Ther. 2006 Feb;5(2):174-9
references: 16340308
references: J Nucl Med. 2010 Aug;51(8):1167-70
references: 20660380
references: BMC Cancer. 2009 Nov 16;9:399
references: 19917123
references: Neurol Res. 2013 Oct;35(8):821-8
references: 23651652
references: FEBS Lett. 2007 Jul 31;581(19):3582-91
references: 17586500
references: Br J Cancer. 2006 Mar 27;94(6):863-9
references: 16495919
references: Clin Cancer Res. 2008 May 15;14(10):3193-203
references: 18483388
references: J Cancer Res Clin Oncol. 1999;125(3-4):156-65
references: 10235469
references: AAPS J. 2007 May 11;9(2):E128-47
references: 17614355
references: Blood. 2008 Feb 15;111(4):1834-9
references: 18048643
references: Mol Pharm. 2009 May-Jun;6(3):928-39
references: 19278222
references: Hum Gene Ther. 1999 Dec 10;10(18):2941-52
references: 10609655
references: Cancer Res. 1996 Dec 15;56(24):5754-7
references: 8971187
references: Nanomedicine (Lond). 2008 Dec;3(6):761-76
references: 19025451
references: Cancer Res. 2004 Jul 15;64(14):4849-57
references: 15256455
references: Nat Rev Cancer. 2004 Oct;4(10):806-13
references: 15510161
references: Drug Resist Updat. 2003 Jun;6(3):111-27
references: 12860459
references: Cancer Res. 2001 Jan 15;61(2):749-58
references: 11212278
references: Gen Pharmacol. 1996 Dec;27(8):1283-91
references: 9304397
references: Cancer Res. 2008 Dec 1;68(23):9809-16
references: 19047160
references: Int J Nanomedicine. 2011;6:2889-98
references: 22131835
references: Science. 2002 May 31;296(5573):1655-7
references: 12040186
references: Cancer Biol Ther. 2007 Jun;6(6):920-9
references: 17534143
references: Mol Pharmacol. 1995 Jan;47(1):51-6
references: 7838133
references: Br J Cancer. 2002 Mar 4;86(5):737-43
references: 11875736
references: J Control Release. 2012 Aug 20;162(1):45-55
references: 22698943
references: Cancer Res. 1987 Jun 15;47(12):3039-51
references: 3555767
references: Cancer. 2001 Sep 15;92(6):1577-90
references: 11745237
references: Curr Pharm Des. 2006;12(3):273-86
references: 16454744
references: Mol Cancer Ther. 2010 Jun;9(6):1798-808
references: 20515941
references: Integr Biol (Camb). 2013 Jan;5(1):96-107
references: 22869005
references: J Biol Chem. 2001 Aug 24;276(34):32313-21
references: 11402022
references: Br J Cancer. 1999 Feb;79(5-6):843-9
references: 10070879
references: Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55
references: 17092599
references: Clin Cancer Res. 2002 Jul;8(7):2286-91
references: 12114432
references: Cancer Lett. 2006 May 18;236(2):302-8
references: 15990222
references: Haematologica. 2001 Feb;86(2):121-7
references: 11224479
references: Biomaterials. 2013 Jul;34(21):5294-302
references: 23562171
references: Cancer Chemother Pharmacol. 1994;33(6):504-8
references: 8137462
references: Bioconjug Chem. 2006 Jul-Aug;17(4):943-9
references: 16848401
references: Ochsner J. 2013 Spring;13(1):109-18
references: 23531695
references: J Control Release. 2008 Mar 20;126(3):246-54
references: 18215787
references: ACS Nano. 2011 May 24;5(5):3679-92
references: 21462992
references: Cancer. 2005 Aug 15;104(4):682-91
references: 15986399
references: Cancer Res. 1992 Apr 1;52(7):1993-5
references: 1551128
references: Cancer Res. 1998 May 1;58(9):1808-12
references: 9581817
references: Cancer Res. 1992 Nov 15;52(22):6371-4
references: 1423283
references: Biomaterials. 2012 Mar;33(7):2272-81
references: 22177840
references: Drug Resist Updat. 2011 Jun;14(3):150-63
references: 21330184
references: Mol Cancer Ther. 2006 May;5(5):1275-9
references: 16731760
references: J Cell Sci. 2000 Jun;113 ( Pt 11):2011-21
references: 10806112
references: Cancer Chemother Pharmacol. 2006 Dec;58(6):776-84
references: 16532342
references: Vasc Cell. 2011 Nov 14;3:26
references: 22082307
references: Eur J Pharm Biopharm. 2008 Mar;68(3):545-54
references: 17881199
references: Drug Discov Today. 2007 Oct;12(19-20):853-9
references: 17933687
references: Mol Cancer Res. 2006 Feb;4(2):61-70
references: 16513837
references: Biochem Biophys Res Commun. 2007 Jun 1;357(2):511-6
references: 17434451
references: Angew Chem Int Ed Engl. 2004 Nov 26;43(46):6323-7
references: 15558662
references: Nat Med. 2004 Jun;10(6):594-601
references: 15156201
references: Anticancer Res. 1995 Jan-Feb;15(1):219-23
references: 7733636
references: Mol Pharm. 2013 May 6;10(5):1901-9
references: 23570548
references: Anticancer Drugs. 2004 Oct;15(9):861-9
references: 15457126
references: Small. 2009 Dec;5(23):2673-7
references: 19780069
references: Exp Oncol. 2008 Mar;30(1):29-34
references: 18438338
references: Cold Spring Harb Symp Quant Biol. 1994;59:661-72
references: 7587127
references: J Control Release. 2005 Mar 21;103(2):405-18
references: 15763623
references: Biomaterials. 2012 Feb;33(4):1170-9
references: 22061491
references: Clin Cancer Res. 2003 Jun;9(6):2335-41
references: 12796403
references: J Control Release. 2006 Nov 28;116(2):123-9
references: 16831481
references: Transfus Clin Biol. 2005 Feb;12(1):5-10
references: 15814285
references: ACS Nano. 2011 Jun 28;5(6):4284-92
references: 21513353
references: Cancer Treat Rev. 2003 Aug;29(4):297-307
references: 12927570
references: Nature. 1992 Jul 2;358(6381):15-6
references: 1614522
references: Oncogene. 2012 May 10;31(19):2412-22
references: 21996734
references: J Control Release. 2009 Dec 16;140(3):294-300
references: 19409432
references: Mol Biosyst. 2011 May;7(5):1512-22
references: 21350763
references: Trends Pharmacol Sci. 2006 Jan;27(1):17-24
references: 16337012
references: Pharmacol Ther. 2007 Feb;113(2):229-46
references: 17046066
references: Drug Resist Updat. 2005 Dec;8(6):339-43
references: 16338161
references: Cancer Res. 1994 Jan 15;54(2):357-61
references: 8275468
references: Adv Mater. 2012 Jul 17;24(27):3659-65
references: 22678851
references: Cell Death Differ. 2002 Dec;9(12):1334-42
references: 12478470
references: Nanotechnology. 2011 Oct 14;22(41):415103
references: 21914940
references: J Drug Deliv. 2013;2013:705265
references: 23533772
references: Biomaterials. 2012 Sep;33(27):6580-91
references: 22717365
references: Nat Rev Cancer. 2009 Jan;9(1):28-39
references: 19104514
references: Cancer Lett. 2006 Jun 8;237(1):10-21
references: 16002209
references: Annu Rev Cell Biol. 1992;8:67-113
references: 1282354
references: Cancer Res. 1992 Oct 1;52(19):5144-53
references: 1327501
references: Nat Rev Cancer. 2004 Jun;4(6):437-47
references: 15170446
references: Int J Pharm. 2011 Jun 15;411(1-2):206-14
references: 21443937
references: J Control Release. 2012 Aug 10;161(3):884-92
references: 22587941
references: Cancer Res. 2006 Oct 1;66(19):9682-90
references: 17018626
references: J Control Release. 2010 Jul 1;145(1):66-73
references: 20346382
references: ACS Nano. 2013 Mar 26;7(3):2860-71
references: 23451830
references: Biomaterials. 2012 Mar;33(9):2780-90
references: 22243797
references: Med Res Rev. 2013 Jan;33(1):33-53
references: 21523793
references: Cancer Res. 2004 Apr 1;64(7):2333-7
references: 15059881
references: Br J Pharmacol. 2007 May;151(2):163-74
references: 17375082
references: Cell Death Dis. 2012 Jan 26;3:e260
references: 22278287
references: Clin Pharmacokinet. 1995 Feb;28(2):126-42
references: 7736688
references: J Interferon Cytokine Res. 2001 Aug;21(8):553-66
references: 11559433
references: Cancer Res. 2007 Jan 15;67(2):709-17
references: 17234782
references: Nanomedicine (Lond). 2012 Jan;7(1):65-78
references: 22191778
references: Br J Cancer Suppl. 1996 Jul;27:S247-51
references: 8763890
references: Nano Res. 2009 Apr 17;2(4):279-291
references: 20052401
references: Eur J Pharm Sci. 2009 Jun 28;37(3-4):300-5
references: 19491019
references: Mol Pharm. 2004 May-Jun;1(3):211-9
references: 15981924
references: Cell Death Differ. 2000 Jul;7(7):682-3
references: 11023343
references: J Cell Biochem. 2009 Aug 15;107(6):1053-62
references: 19479945
references: J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54
references: 17895480
references: Bioconjug Chem. 2007 Mar-Apr;18(2):363-70
references: 17309227
references: Anticancer Drugs. 2004 Jun;15(5):421-6
references: 15166615
references: Mutat Res. 2005 Jan 6;569(1-2):75-85
references: 15603753
references: Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):953-61
references: 2211264
references: Cancer Res. 1992 Nov 15;52(22):6175-81
references: 1358431
references: Int J Pharm. 2012 Sep 15;434(1-2):9-19
references: 22617794
references: Int J Cancer. 2008 Jan 15;122(2):452-60
references: 17918179
references: Cancer Res. 1992 Jan 1;52(1):144-8
references: 1727375
references: J Clin Oncol. 2008 Jun 1;26(16):2674-82
references: 18509179
references: Cancer Chemother Pharmacol. 2009 Mar;63(4):571-82
references: 19083000
references: Cancer Res. 2007 May 15;67(10):4843-50
references: 17510414
references: J Cell Biochem. 2007 Jul 1;101(4):805-15
references: 17226777
references: Nature. 2004 Feb 19;427(6976):695
references: 14973470
references: Blood. 1993 Aug 15;82(4):1288-99
references: 8102561
references: Clin Cancer Res. 2004 Apr 1;10(7):2299-306
references: 15073105
references: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):733-41
references: 17852559
references: Klin Padiatr. 2007 May-Jun;219(3):127-33
references: 17525905
references: Cancer Gene Ther. 2008 Jan;15(1):29-39
references: 17828283
references: Adv Cancer Res. 2005;94:143-96
references: 16096001
references: Cancer Res. 2002 Sep 1;62(17):5035-40
references: 12208758
references: Nat Rev Cancer. 2011 Jun;11(6):393-410
references: 21606941
references: Cancer Res. 2010 Feb 15;70(4):1513-23
references: 20145140
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Nat Med. 1999 Jun;5(6):662-8
references: 10371505
references: Methods Mol Biol. 2008;437:183-216
references: 18369970
references: Br J Cancer. 1972 Aug;26(4):239-57
references: 4561027
references: Cancer Res. 2005 Aug 1;65(15):6910-8
references: 16061675
references: Cancer Res. 1998 Apr 1;58(7):1408-16
references: 9537241
references: Urology. 2007 Jan;69(1):34-7
references: 17270609
references: Anticancer Res. 1998 Nov-Dec;18(6A):4147-58
references: 9891460
references: Biochim Biophys Acta. 2011 Jun;1807(6):735-45
references: 21453675
references: Cancer Res. 1993 May 15;53(10 Suppl):2204-7
references: 8485703
references: J Cell Biochem. 2007 Jul 1;101(4):937-49
references: 17171643
references: J Biol Chem. 2009 May 8;284(19):12905-16
references: 19276080
references: J Control Release. 2008 Jul 14;129(2):107-16
references: 18486981
references: Curr Opin Cell Biol. 2005 Dec;17(6):631-6
references: 16226451
references: J Liposome Res. 2009;19(4):322-31
references: 19863167
references: Cancer Metastasis Rev. 2001;20(1-2):123-32
references: 11831640
references: Int J Nanomedicine. 2010 Feb 02;5:25-36
references: 20161985
references: J Clin Oncol. 2001 Jun 15;19(12):2975-82
references: 11408492
references: Annu Rev Med. 2002;53:615-27
references: 11818492
references: Cancer Res. 1996 Sep 15;56(18):4171-9
references: 8797588
references: Int J Pharm. 2011 Sep 15;416(1):296-9
references: 21703341
references: Int J Cancer. 2002 Jul 1;100(1):30-6
references: 12115583
references: Trends Biochem Sci. 1999 Feb;24(2):68-72
references: 10098401
references: Clin Cancer Res. 2007 Apr 1;13(7):2038-45
references: 17404084
references: Nat Rev Cancer. 2008 Sep;8(9):705-13
references: 19143055
references: Biochem Pharmacol. 2006 Mar 14;71(6):872-81
references: 16436273
references: Nature. 2000 Sep 14;407(6801):249-57
references: 11001068
references: Clin Cancer Res. 1995 Nov;1(11):1301-10
references: 9815925
references: J Biotechnol. 2010 Jul 1;148(1):3-15
references: 20097238
references: Int J Cancer. 2007 Oct 15;121(8):1830-8
references: 17557285
references: Clin Cancer Res. 2001 Nov;7(11):3399-403
references: 11705854
references: Int J Cancer. 1993 Feb 20;53(4):574-8
references: 8094712
references: Prostate. 2011 Dec;71(16):1796-809
references: 21480310
references: Cell Mol Life Sci. 2008 Oct;65(20):3145-67
references: 18581055
references: Cancer Res. 2000 Dec 15;60(24):7075-83
references: 11156414
references: Semin Radiat Oncol. 2004 Jul;14(3):249-58
references: 15254868
references: Biomaterials. 2010 May;31(15):4426-33
references: 20188412
references: Cancer Treat Rev. 2008 Nov;34(7):592-602
references: 18538481
references: Int J Pharm. 2012 Sep 15;434(1-2):488-93
references: 22613208
references: Surg Oncol. 2012 Sep;21(3):172-7
references: 21963199
references: Science. 1956 Feb 24;123(3191):309-14
references: 13298683
references: Nature. 2006 May 25;441(7092):437-43
references: 16724055
references: J Control Release. 2003 Jul 31;90(3):363-74
references: 12880703
references: Cancer Cell Int. 2005 Jul 07;5(1):20
references: 16001980
references: J Natl Cancer Inst. 2001 Feb 21;93(4):266-76
references: 11181773